Navigation Links
2 carotid artery stenting studies show results comparable to AHA guidelines
Date:10/23/2007

Washington D.C., October 23, 2007 - Two carotid stenting trials examining patient outcomes demonstrated results that are comparable to guidelines established by the American Heart Association (AHA) for patients treated with carotid artery surgery. The results of these studies were presented today at the Cardiovascular Research Foundation's 19th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium by William A. Gray, M.D., FACC, associate professor of clinical medicine at Columbia University College of Physicians and Surgeons and director of Endovascular Services at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center in New York. Dr. Gray is the director of Endovascular Services at the Cardiovascular Research Foundation.

An interim analysis of patients treated with carotid stents in Abbotts CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) and EXACT (Emboshield and Xact Post Approval Carotid Stent Trial) post-marketing trials, which enrolled 4,111 patients in over 150 sites, demonstrated 30 day patient outcome results consistent with longstanding AHA guidelines for patients with a severe carotid stenosis but who do not have symptoms. These guidelines recommend that rates of complications for carotid artery surgery to prevent stroke be less than 3 percent for patients without symptoms of stroke (asymptomatic) and 6 percent for patients with symptoms of stroke (symptomatic).

In these two well-conducted carotid artery stenting studies, carotid stenting has achieved outcomes comparable guidelines established for patients who undergo carotid surgery, and has done so in a population of patients who are at high risk for experiencing adverse events from surgery, said Dr. Gray. This is a significant report because this is the first time that these guidelines have been achieved by any revascularization therapy in a large, multi-center exa
'/>"/>

Contact: Alex Lyda
mal2133@columbia.edu
917-755-0354
Columbia University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Columbia study shows widely used artery clearing device does not help patients during heart attack
2. Measuring artery repair cells could become new heart disease test
3. Studies reveal methods viruses use to sidestep immune system
4. New studies suggest airborne SARS transmission is possible
5. Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine
6. Two studies document rise of superbugs in the environment
7. UI researcher studies deafness in fruit flies, humans
8. Biased reporting found in cancer prognostic studies
9. Fruit fly studies open new window on cancer research
10. Why do aneurysms form? New studies suggest leading role for white blood cells
11. Studies clarify risk factors for mother-to-child transmission of hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...f experts in biomechanics and physiology from six ...ssachusetts Institute of Technologys Media Lab, re... Oscar Pistorius, a 21-year-old South African bila...nfair advantage in the 400-meter race. Their concl...iversity Locomotion Laboratory, under the directio...
(Date:5/15/2008)...upposed to inch forward over eons, but sometimes, ...hreespine stickleback, the process can go in relat...y researchers at Fred Hutchinson Cancer Research C...ay 20 issue of Current Biology (Cell Press). , Th...olution in nature, said senior author Catherine Ka...
(Date:5/15/2008)...s divided into two separate groups within Africa f...iv University mathematician. Climate change, reduc...caused and maintained the separation. , Dr. Sah...ces at Tel Aviv University, worked with team leade...alyze African DNA. Their goal was to study obscure...
(Date:5/15/2008)... high school biology students can recite that gene...nger RNA (mRNA), which is then translated into pro...g studentsand many scientistsscrambling for update...logical Studies investigator Joseph Ecker, Ph.D., ...opmental Cell, shows that the RNA world is more co...
Breaking Biology News(10 mins):Breaking news: Study revives Olympic prospects for amputee sprinter 2Breaking news: Study revives Olympic prospects for amputee sprinter 3Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 2Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 3Long lost sisters 2Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3Sales Executives Finding Value in Best Practice Database 17232 1Sales Executives Finding Value in Best Practice Database 17232 2Pharma Manufacturing Quality 3A Optimizing Processes for FDA Compliance 17228 1Pharma Manufacturing Quality 3A Optimizing Processes for FDA Compliance 17228 2High anxiety 3F 17227 3/ 1QMed Inc Receives NASDAQ Delisting Letter 17225 1QMed Inc Receives NASDAQ Delisting Letter 17225 2QMed Inc Receives NASDAQ Delisting Letter 17225 3
...e abounds with examples of bacteria that can thriv...cals, for instance. In a paper published online in...S) May 25, University of Michigan researchers show...her potentially harmful chemicals known as free ra...insights could lead to new ways of engineering bac...
...tists at the Forsyth Institute have found that thr...common form of oral cancer--a discovery the resear...or the often-fatal disease. , The findings also o...e way, play a causal role. , The current discovery...Medicine, suggests that elevated levels of three p...
...rch into the genetics of barley could lead to impr...he production of whisky and beer. Scientists funde...nces Research Council (BBSRC) are beginning a new ...ecific characteristics of different barley varieti...ish Crop Research Institute, Birmingham University...
...e latest version of the hide-and-seek game between...have found that a virus appears to cloak itself wi...evade detection and destruction by immune cells. ,...HMI) researchers in an article published in the Ju...ow how a virus uses the gene silencing machinery f...
Other Biology News:A radical solution for environmental pollution 2Forsyth scientists find three bacteria associated with oral cancer 2Forsyth scientists find three bacteria associated with oral cancer 3Whisky fans can drink to crop research 2Virus uses tiny RNA to evade the immune system 2Virus uses tiny RNA to evade the immune system 3
(Date:5/16/2008)..., May 16 /- Metametrix Institute (, h...ay the publication of,Laboratory Evaluations for I...ritten and edited by Richard S. Lord and J. Alexan...n by Bralley and Lord, Laboratory,Evaluations in M...e is the,new educational arm of Metametrix Inc., a...
(Date:5/16/2008)...May 16 /- Alba Therapeutics Corporati...ized its first patient in a,twelve-week Phase IIb ...f,intestinal barrier dysfunction, for the treatmen... global multi-center, randomized, double-blind,pl...and histological,efficacy, safety and tolerability...
(Date:5/16/2008)...itzerland, May 16 /- Arpida...od and Drug Administration,(FDA) has accepted for ...ous iclaprim in the treatment of complicated Skin ...leted the submission of the NDA to,the agency in M...eview to,the iclaprim NDA and has established the ...
(Date:5/15/2008)... nanostructures that scatter and channel light, Un...eers are working toward thin-film single junction ...nt sunlight-to-electricity conversion efficiencies...l limit of 31 percent efficiency for conventional ...ing boost from the U.S. Department of Energys Sola...
Breaking Biology Technology:Introducing Laboratory Evaluations for Integrative and Functional Medicine 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3UC San Diego nanostructures will raise thin-film solar cell efficiency 2
... Mike Byrom, Ambion, Inc., More , ...iRNA experiments to , elucidate...RNA , effect is only evaluated ... approach overlooks the true subject of most siRN...ect caused by a reduction in the target protein. ,...
... David Brown (Senior Scientist, , ...lization that RNA interference (RNAi) , ...an gene function , studies occu... publication describing the use of sma...in mammalian cells in 2001. In less than two years...
... Appropriate storage of cells or tissue , ...tical for preservation of , int...eous , solution designed specif... during storage of fresh tissue and cell sample...ed questions regarding <A , hre...
...zales, Ambion, Inc., , ...from , heterogenous samples is ... expression profiles of specific cell types. ... (LCM), developed in a collaborative effort , ...specifically to isolate , cance...
Other Biology Technology:RNAi: Get the Whole Story 2RNAi: Get the Whole Story 3RNAi: Get the Whole Story 4RNAi: Get the Whole Story 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 2RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 3RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 4RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 6RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 8RNAlater FAQs: Preserving RNA Before Isolation 2RNAlater FAQs: Preserving RNA Before Isolation 3RNAlater FAQs: Preserving RNA Before Isolation 4RNA from LCM Samples 2RNA from LCM Samples 3
... is commonly used as a fusion partner when express...as been reported to enhance the production and in ...When expressed in a soluble, properly folded form,...ilized glutathione. Gentle elution is achieved wit...
The Bio-Stack is compatible with BioTeks microplate washers, dispensers and detection systems. Speed, ease of use and walkaway automation are guaranteed for any routine microplate process. When used
...rip washer which can come equipped with our patent...rough design allows for independent control of the...shing and overflow protection in both 96- and 384-...aspirate tubes into a much smaller 384-well is sol...
...eaction interface (CRI) system*, which provides si... interferences. The result is faster, more flexibl...complex multipole or scanning quadrupole ion guide...strument parameters, including CRI gases, instrume...
Biology Products: